Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
F 12.09 0.33% 0.04
NVCR closed up 0.33 percent on Friday, April 19, 2024, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 2
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal 0.33%
Oversold Stochastic Weakness 0.33%
NR7 Range Contraction 0.33%
NR7-2 Range Contraction 0.33%
Narrow Range Bar Range Contraction 0.33%
Lower Bollinger Band Walk Weakness 0.33%
Below Lower BB Weakness 0.33%
Down 3 Days in a Row Weakness 0.33%

   Recent Intraday Alerts

Alert Time
Up 2% about 23 hours ago
Up 1% about 23 hours ago
Down 1% about 24 hours ago
Up 3% 2 days ago
Up 2% 2 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Blastoma Small Cell Lung Cancer Glioblastoma Brain Tumor Solid Tumor Cancers Aging Associated Diseases Metastases Brain Cancer Mesothelioma

Is NVCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 83.6
52 Week Low 10.87
Average Volume 1,345,336
200-Day Moving Average 18.39
50-Day Moving Average 14.74
20-Day Moving Average 13.74
10-Day Moving Average 13.27
Average True Range 0.81
RSI (14) 34.64
ADX 16.06
+DI 19.37
-DI 27.84
Chandelier Exit (Long, 3 ATRs) 13.62
Chandelier Exit (Short, 3 ATRs) 14.32
Upper Bollinger Bands 15.90
Lower Bollinger Band 11.59
Percent B (%b) 0.12
BandWidth 31.36
MACD Line -0.66
MACD Signal Line -0.43
MACD Histogram -0.2254
Fundamentals Value
Market Cap 1.29 Billion
Num Shares 107 Million
EPS -1.86
Price-to-Earnings (P/E) Ratio -6.50
Price-to-Sales 3.35
Price-to-Book 4.16
PEG Ratio -0.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.74
Resistance 3 (R3) 12.74 12.53 12.63
Resistance 2 (R2) 12.53 12.37 12.53 12.59
Resistance 1 (R1) 12.31 12.26 12.42 12.31 12.56
Pivot Point 12.10 12.10 12.16 12.10 12.10
Support 1 (S1) 11.88 11.94 11.99 11.88 11.62
Support 2 (S2) 11.67 11.83 11.67 11.59
Support 3 (S3) 11.45 11.67 11.55
Support 4 (S4) 11.45